When are topical calcineurin inhibitors recommended for hypopigmentation?

Hypopigmentation means that an area of skin is lighter than the surrounding skin. It is a sign rather than one single diagnosis and can follow inflammation, irritation, infection, injury, or an immune condition. A topical calcineurin inhibitor is an anti-inflammatory medicine that may support pigment recovery when inflammation is contributing to the colour change. It will not help every light patch, and the original cause may need separate treatment. A clinician may examine the borders, surface, distribution, and history before recommending it.

Use the medicine only on the areas and schedule prescribed. Apply it with clean hands, avoid the eyes and lips, and continue gentle skincare that does not irritate the area. Sun protection can reduce tanning of surrounding skin, making contrast less noticeable and allowing colour changes to be judged more fairly. Avoid home bleaching, harsh scrubs, and unprescribed steroid combinations. Mention any burning, swelling, blistering, or worsening redness rather than increasing the amount yourself.

Seek assessment if light patches spread quickly, become scaly or painful, lose hair, or involve the eyes or mouth. Arrange a review if the diagnosis is uncertain, new areas continue appearing, or there is no improvement during the planned follow-up period. A changing pattern may indicate that the underlying cause needs reconsideration.

Ask what is causing the hypopigmentation, what improvement would look like, and how long pigment recovery may take. Confirm where to apply the medicine, how to protect surrounding skin, and when the diagnosis should be revisited.